This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Gair Ford, Ph.D.
Regulatory CMC Director at Astrazeneca


Gair Ford is a Regulatory CMC Director at AstraZeneca, based in the UK with 25 years’ experience in the Pharmaceutical industry. A chemist by training Gair moved into regulatory CMC following around 20 years in Process Chemistry and represents AstraZeneca externally on a number of consortia including EPOC (European Oligonucleotide Consortium).

Agenda Sessions

  • Nitrosamine and Mutagenic Impurity Risk Assessments in Oligonucleotides